This week's poll question is the third in our series of questions looking at the drug treatments myeloma patients are receiving now, or have received in the past.
The previous two poll questions were about the first two novel agents for myeloma, thalidomide and Velcade.
This week's question is about the third and most recent novel agent, Revlimid (lenalidomide).
As usual, there are a few clarifications to the poll question:
First, this question is only for readers who have active multiple myeloma (that is, not smoldering myeloma, and not MGUS).
Second, if you are a caregiver or family member of someone who has active myeloma, feel free to answer on their behalf
As always, feel free to post comments, thoughts, or feedback in the space below. They can be very useful to other readers.
For the previous two poll questions similar to this week's question, see these links:
https://myelomabeacon.org/forum/weekly-poll-treatment-with-thalidomide-active-myeloma-t768.html
https://myelomabeacon.org/forum/weekly-poll-treatment-with-velcade-active-myeloma-t805.html
Forums
3 posts
• Page 1 of 1
Re: Weekly Poll - Treatment With Revlimid (Active Myeloma)
It has not worked for me at all.
-
desqueen5
Re: Weekly Poll - Treatment With Revlimid (Active Myeloma)
Rev was not part of my induction / transplant regime. Was offered Thalidomide for maintenence as that it was what funded but chose not to take it. Decided against it due to the side effects. Transplant was July 2010 and am in CR status.
-
guest
3 posts
• Page 1 of 1